# Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A

> **NCT01434511** · PHASE3 · TERMINATED · sponsor: **Baxalta now part of Shire** · enrollment: 1 (actual)

## Conditions studied

- Hemophilia A

## Interventions

- **BIOLOGICAL:** OBI-1

## Key facts

- **NCT ID:** NCT01434511
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-10-03
- **Primary completion:** 2013-07-29
- **Final completion:** 2013-07-29
- **Target enrollment:** 1 (ACTUAL)
- **Last updated:** 2021-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434511, "Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01434511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*